Granted Patent
B2
US 7,329,504 · App. 11/493,489 · Granted Feb 12, 2008
Methods of preventing or treating cell migration mediated conditions or diseases
Assignee:
Wisconsin Alumni Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to methods of identifying agents which modulate the activity of PIPKIγ661. Methods of using such agents to prevent or treat a cell migration-mediated condition or disease in a subject are also provided.
Claims (1)
1. A method for identifying an agent that modulates cell focal adhesion assembly comprising contacting a cell which lacks active PIPKIγ661 or which overexpresses PIPKIγ661 with a test agent and measuring the adherence of said cell to a surface, wherein a difference in the adherence of the cell to the surface in the presence of the test agent as compared to the adherence of the cell to the surface in the absence of the test agent is indicative of the agent modulating cell focal adhesion assembly.
Assignments (2)
CONFIRMATORY LICENSE
Recorded May 25, 2018
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: WISCONSIN ALUMNI RESEARCH FOUNDATION; NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 047051/0681 →
CONFIRMATORY LICENSE
Recorded Apr 9, 2018
From: UNIVERSITY OF WISCONSIN-MADISON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045865/0921 →
Continuity (2)